RecruitingNCT07421102
Feasibility of mailing buprenorphine after hospital discharge
About this title
Read the official source — NCT07421102Interventional studyAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
What will I do during this study?
Adults discharged from hospital after starting buprenorphine, with a stable South Carolina mailing address and other listed criteria, may be eligible for this pilot at the Medical University of South Carolina in Charleston. The study mails monthly medication refills and follows delivery, participant-reported experience, and treatment retention at 1, 3, and 6 months. It is evaluating feasibility and early outcomes; it does not offer treatment advice. Other eligibility criteria apply.
- Listed locations
- Charleston and 1 more locationSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 8, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 20
- Sponsor
- Medical University of South Carolina
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07421102
- Official title
Show the full official title
A Pragmatic Remote Approach to Improve Transitions of Care and Retention in Opioid Use Disorder Treatment
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Charleston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Medical University of South Carolina, a university.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
